Oorsprong van het eerstegraads netwerk van Robert E. Hinckley
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Bimeda, Inc.
Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Bimeda, Inc. manufactures veterinary pharmaceuticals and animal health care products. The company has operations in the United Kingdom, Canada, the United States, Mexico, and Ireland. The firm was founded in 1997 and is headquartered in Oakbrook, IL
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Robert E. Hinckley via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
IMMUCELL CORPORATION | Biotechnology | Director/Board Member | |
Roberts Pharmaceutical Corp.
Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Agri-Laboratories Ltd.
Agri-Laboratories Ltd. Agricultural Commodities/MillingProcess Industries Agri-Laboratories Ltd. develops and produces animal feeds and health products. Its products include Colostrx CS and Colostrx CR; ISite XP, MpB Guard and Pulmo-Guard PH-M vaccines; and the VetGun. The company was founded in 1984 and is headquartered in St. Joseph, MO. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
Valera Pharmaceuticals, Inc.
Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
CATALYST PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VIATAR CTC SOLUTIONS INC. | Medical Specialties | Director/Board Member | |
Iowa State University | College/University | Undergraduate Degree | |
Royal College of Surgeons | College/University | Doctorate Degree | |
Boehringer Ingelheim Animal Health USA, Inc.
Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Biotechnology | Sales & Marketing | |
Biovail Technologies Ltd. | President | ||
Oceana Therapeutics, Inc.
Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Pharmaceuticals: Major | Founder | |
Bimeda-MTC Animal Health, Inc.
Bimeda-MTC Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Bimeda-MTC Animal Health, Inc. manufactures, markets and distributes animal health products and veterinary pharmaceuticals. The firm offers its products for cattle, sheep, goats, swine, horses, poultry, dogs and cats. It provides products under the categories of anti-inflammatory, anti-microbial, disinfectants/antiseptic, hormonal, intramammary, nutritional and sedative. The company was founded in 1964 and is headquartered in Cambridge, Canada. | Pharmaceuticals: Major | President | |
Axxiom Consulting LLC | Chief Operating Officer | ||
Bimeda Animal Health
Bimeda Animal Health Pharmaceuticals: MajorHealth Technology Part of Bimeda Holdings Ltd., Bimeda Animal Health is a leading manufacturer, marketer, and distributor of animal health products and veterinary pharmaceuticals. The company is based in Tallaght, Ireland and is committed to instilling a culture of sustainability to help govern their policies and decision making in all parts of the business. With Irish roots and half a century of experience, Bimeda has seven manufacturing facilities around the world, all operating to the highest regulatory standards. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Aramis Biosciences, Inc.
Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Pharmaceuticals: Major | Chief Executive Officer | |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Generic | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 23 |
Ierland | 3 |
Canada | 2 |
Israël | 2 |
Sectoraal
Health Technology | 20 |
Process Industries | 3 |
Consumer Services | 3 |
Finance | 2 |
Operationeel
Director/Board Member | 13 |
President | 8 |
Chief Executive Officer | 7 |
Corporate Officer/Principal | 6 |
Independent Dir/Board Member | 4 |
Sterkste connecties
Insiders | |
---|---|
David Tierney | 19 |
David Cunningham | 8 |
Gavin L. Tierney | 2 |
- Beurs
- Insiders
- Robert E. Hinckley
- Bedrijfsconnecties